Logo image of DUOT

DUOS TECHNOLOGIES GROUP INC (DUOT) Stock Fundamental Analysis

USA - NASDAQ:DUOT - US2660424076 - Common Stock

7.7 USD
+0.19 (+2.53%)
Last: 9/29/2025, 2:49:00 PM
Fundamental Rating

1

Overall DUOT gets a fundamental rating of 1 out of 10. We evaluated DUOT against 281 industry peers in the Software industry. DUOT may be in some trouble as it scores bad on both profitability and health. DUOT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DUOT had negative earnings in the past year.
In the past year DUOT has reported a negative cash flow from operations.
DUOT had negative earnings in each of the past 5 years.
In the past 5 years DUOT always reported negative operating cash flow.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -33.42%, DUOT is doing worse than 76.51% of the companies in the same industry.
DUOT has a Return On Equity of -219.87%. This is amonst the worse of the industry: DUOT underperforms 81.85% of its industry peers.
Industry RankSector Rank
ROA -33.42%
ROE -219.87%
ROIC N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

DUOT has a Gross Margin of 22.24%. This is amonst the worse of the industry: DUOT underperforms 80.43% of its industry peers.
DUOT's Gross Margin has declined in the last couple of years.
DUOT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DUOT has more shares outstanding than it did 1 year ago.
DUOT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DUOT is higher compared to a year ago.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

DUOT has an Altman-Z score of -1.05. This is a bad value and indicates that DUOT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.05, DUOT is not doing good in the industry: 75.44% of the companies in the same industry are doing better.
DUOT has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.37, DUOT is doing worse than 61.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -1.05
ROIC/WACCN/A
WACC11.33%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

A Current Ratio of 0.37 indicates that DUOT may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.37, DUOT is doing worse than 92.53% of the companies in the same industry.
A Quick Ratio of 0.33 indicates that DUOT may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.33, DUOT is doing worse than 93.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.33
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.54% over the past year.
Looking at the last year, DUOT shows a very strong growth in Revenue. The Revenue has grown by 172.93%.
The Revenue for DUOT have been decreasing by -11.80% on average. This is quite bad
EPS 1Y (TTM)35.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
Revenue 1Y (TTM)172.93%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%279.74%

3.2 Future

The Earnings Per Share is expected to grow by 42.19% on average over the next years. This is a very strong growth
DUOT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 117.51% yearly.
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 251.63 indicates a quite expensive valuation of DUOT.
Based on the Price/Forward Earnings ratio, DUOT is valued a bit more expensive than 64.06% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.05. DUOT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 251.63
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DUOT does not grow enough to justify the current Price/Earnings ratio.
DUOT's earnings are expected to grow with 42.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.19%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DUOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (9/29/2025, 2:49:00 PM)

7.7

+0.19 (+2.53%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-14 2025-08-14/amc
Earnings (Next)11-17 2025-11-17
Inst Owners15.17%
Inst Owner Change13.36%
Ins Owners13.15%
Ins Owner Change-1.17%
Market Cap155.93M
Analysts82.5
Price Target12.75 (65.58%)
Short Float %3.79%
Short Ratio1.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.42%
Min EPS beat(2)-36.8%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-10.42%
Min EPS beat(4)-36.8%
Max EPS beat(4)29.41%
EPS beat(8)3
Avg EPS beat(8)-20.7%
EPS beat(12)5
Avg EPS beat(12)-22.26%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.26%
Min Revenue beat(2)12.9%
Max Revenue beat(2)13.61%
Revenue beat(4)3
Avg Revenue beat(4)-2%
Min Revenue beat(4)-47.91%
Max Revenue beat(4)13.61%
Revenue beat(8)4
Avg Revenue beat(8)-12.85%
Revenue beat(12)5
Avg Revenue beat(12)-14.94%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-38.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 251.63
P/S 10.13
P/FCF N/A
P/OCF N/A
P/B 32.95
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.07
EYN/A
EPS(NY)0.03
Fwd EY0.4%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.76
BVpS0.23
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.42%
ROE -219.87%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.24%
FCFM N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 66.09%
Cap/Sales 15.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.33
Altman-Z -1.05
F-Score4
WACC11.33%
ROIC/WACCN/A
Cap/Depr(3y)127.01%
Cap/Depr(5y)141.85%
Cap/Sales(3y)14.73%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.23%
EPS Next Y62.11%
EPS Next 2Y42.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)172.93%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%279.74%
Revenue Next Year228.83%
Revenue Next 2Y117.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y12.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.36%
OCF growth 3YN/A
OCF growth 5YN/A